NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.

Front Immunol · 2015 · PMC4459093 · PMID 26106390

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

NKp46 was expressed mainly in CD56 bright cells and, in most BCG-treated patients, an increase that did not reach statistical significance in the variation over the time of therapy of the expression of this receptor was observed (Figure 7 C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.